The "try and fail" language is flawed when weight loss is used as the primary measure of success with lifestyle interventions ...

Employers increasingly shift health benefit costs to workers in 2026, while prioritizing mental health and innovative affordability strategies.

The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide ...

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

The researchers first tested their hypothesis by delivering ODN directly to the hindbrain of rats. Once treated, the rats ...

A study from Florida State University uncovers biological and behavioral consequences of weight loss underlying binge-eating in women with bulimia nervosa and related syndromes. The work is published ...

Appetite suppression will always be at its highest on days one to three after injecting Mounjaro and by days six to seven, ...

Study supports utilizing weight history assessment for eating disorders and shows pivotal role of GLP-1 in link between ...

When nurse practitioner Amy Rabon launched Sisterhood Sanctuary’s weight management program in 2019, 25 people signed up, ...

Significant’ weight returned weeks after stopping drug, say researchers who advise patients to adjust expectations.